Shingles Vaccine Offers 4 Years of Protection

Two doses of the recombinant zoster vaccine protect patients for longer than previously known.

Related Keywords

California ,United States ,Rhode Island ,Oakland ,Nicola Klein ,Alexandra Tien ,Us Centers For Disease ,Associates Of Rhode Island ,Vaccine Study Center At Kaiser Permanente ,Vaccine Safety Datalink ,Disease Control ,Vaccine Study Center ,Kaiser Permanente ,Medical Associates ,Vaccine ,Vaccines ,Herpes Zoster ,Shingles ,Adult Vaccines ,Herpes Zoster Vaccine ,Shingles Vaccine ,Patient Safety ,Geriatrics ,Elder Care ,Geriatric Medicine ,Older Adults ,Seniors ,Senior Citizens ,Elderly ,Myalgia ,Muscle Pain ,Immunizations ,Vaccination ,Spain ,Postherpetic Neuralgia ,Pain Management ,Adverse Effects ,Side Effects ,Antiviral ,Amciclovir ,Alacyclovir ,Clinical Research ,